Screener
United Therapeutics UTHR Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from United Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001082554-26-000020
FAQ
- What is United Therapeutics's free cash flow margin?
- United Therapeutics (UTHR) reported free cash flow margin of 32.1% in Q1 2026.
- How has United Therapeutics's free cash flow margin changed year-over-year?
- United Therapeutics's free cash flow margin decreased by 14.9% year-over-year, from 37.7% to 32.1%.
- What is the long-term trend for United Therapeutics's free cash flow margin?
- Over 5 years (2020 to 2025), United Therapeutics's free cash flow margin has grown at a -7.0% compound annual growth rate (CAGR), from 46.9% to 32.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about United Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude